AAAAAA

   
Results: 1-9 |
Results: 9
SUBVERSION OF CELL-MEDIATED-IMMUNITY BY LEUKEMIC-CELLS - LESSONS FOR CLINICAL IMMUNOTHERAPY
Authors: BUGGINS AGS HIRST WJR DARLING D GAKEN J PAGLIUCA A FARZANEH F MUFTI GJ
Citation: Ags. Buggins et al., SUBVERSION OF CELL-MEDIATED-IMMUNITY BY LEUKEMIC-CELLS - LESSONS FOR CLINICAL IMMUNOTHERAPY, British Journal of Haematology, 101, 1998, pp. 2-2
CENTRAL ROLE OF SOLUBLE IMMUNOSUPPRESSIVE FACTORS IN THE DEVELOPMENT OF LEUKEMIA-ASSOCIATED IMMUNE DYSFUNCTION
Authors: HIRST WJR BUGGINS AGS PAGLIUCA A MUFTI GJ
Citation: Wjr. Hirst et al., CENTRAL ROLE OF SOLUBLE IMMUNOSUPPRESSIVE FACTORS IN THE DEVELOPMENT OF LEUKEMIA-ASSOCIATED IMMUNE DYSFUNCTION, British Journal of Haematology, 101, 1998, pp. 38-38
VARIABLE EXPRESSION OF CD3-ZETA AND ASSOCIATED PROTEIN-TYROSINE KINASES IN LYMPHOCYTES FROM PATIENTS WITH MYELOID MALIGNANCIES
Authors: BUGGINS AGS HIRST WJR PAGLIUCA A MUFTI GJ
Citation: Ags. Buggins et al., VARIABLE EXPRESSION OF CD3-ZETA AND ASSOCIATED PROTEIN-TYROSINE KINASES IN LYMPHOCYTES FROM PATIENTS WITH MYELOID MALIGNANCIES, British Journal of Haematology, 100(4), 1998, pp. 784-792
IRRADIATED NC ADENOCARCINOMA CELLS TRANSDUCED WITH BOTH B7.1 AND INTERLEUKIN-2 INDUCE CD4(-MEDIATED REJECTION OF ESTABLISHED TUMORS())
Authors: GAKEN JA HOLLINGSWORTH SJ HIRST WJR BUGGINS AGS GALEALAURI J PEAKMAN M KUIPER M PATEL P TOWNER P PATEL PM COLLINS MKL MUFTI GJ FARZANEH F DARLING DC
Citation: Ja. Gaken et al., IRRADIATED NC ADENOCARCINOMA CELLS TRANSDUCED WITH BOTH B7.1 AND INTERLEUKIN-2 INDUCE CD4(-MEDIATED REJECTION OF ESTABLISHED TUMORS()), Human gene therapy, 8(4), 1997, pp. 477-488
LOSS OF CD3-ZETA EXPRESSION IS A LATE EVENT IN THE DEVELOPMENT OF T-CELL DYSFUNCTION IN A MURINE LEUKEMIC MODEL
Authors: HIRST WJR BUGGINS AGS DARLING D GAKEN J TOWNER P FARZANEH F MUFTI GJ
Citation: Wjr. Hirst et al., LOSS OF CD3-ZETA EXPRESSION IS A LATE EVENT IN THE DEVELOPMENT OF T-CELL DYSFUNCTION IN A MURINE LEUKEMIC MODEL, Blood, 88(10), 1996, pp. 3420-3420
CD3-ZETA EXPRESSION IN NK AND T-CELLS FROM PATIENTS WITH MYELOID MALIGNANCIES
Authors: BUGGINS AGS HIRST WJR PAGLIUCA A MUFTI GJ
Citation: Ags. Buggins et al., CD3-ZETA EXPRESSION IN NK AND T-CELLS FROM PATIENTS WITH MYELOID MALIGNANCIES, Blood, 88(10), 1996, pp. 2326-2326
PREDICTING THE SEVERITY OF RHESUS ALLOIMMUNIZATION - MONOCYTE-MEDIATED CHEMILUMINESCENCE VERSUS MATERNAL ANTI-D ANTIBODY ESTIMATION
Authors: BUGGINS AGS THILAGANATHAN B HAMBLEY H NICOLAIDES KH
Citation: Ags. Buggins et al., PREDICTING THE SEVERITY OF RHESUS ALLOIMMUNIZATION - MONOCYTE-MEDIATED CHEMILUMINESCENCE VERSUS MATERNAL ANTI-D ANTIBODY ESTIMATION, British Journal of Haematology, 88(1), 1994, pp. 199-200
FETAL PLASMA TUMOR-NECROSIS-FACTOR CONCENTRATION IN NORMAL-PREGNANCY
Authors: ABBAS A SNIJDERS RJM BUGGINS AGS LAYTON DM NICOLAIDES KH
Citation: A. Abbas et al., FETAL PLASMA TUMOR-NECROSIS-FACTOR CONCENTRATION IN NORMAL-PREGNANCY, Fetal diagnosis and therapy, 8(4), 1993, pp. 230-233
FETAL PLASMA INTERFERON-GAMMA CONCENTRATION IN NORMAL-PREGNANCY
Authors: ABBAS A THILAGANATHAN B BUGGINS AGS LAYTON DM NICOLAIDES KH
Citation: A. Abbas et al., FETAL PLASMA INTERFERON-GAMMA CONCENTRATION IN NORMAL-PREGNANCY, American journal of obstetrics and gynecology, 168(5), 1993, pp. 1414-1416
Risultati: 1-9 |